Cryptococcemia in a patient with COVID-19: A case report

Category Primary study
JournalClin. Case Rep.
Year 2021
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
Epistemonikos ID: a62ab3d8f5092135c4bf9ba216be00c4444221d7
First added on: Jan 07, 2021